My research is centered on developing Advanced Therapy Medicinal Products (ATMPs), in particular, novel clinically relevant drug delivery technologies to facilitate effective nucleic acid-based therapies aimed at high medical need diseases that lack effective treatment. Current work in my group focuses on engineering novel biomaterials and RNA-based therapeutics. We are exploring the potential of RNA molecules (such as short interfering RNAs, messenger RNAs and circular RNAs) to treat and prevent diseases such as sepsis, inflammatory bowel disease and cancer by delivering these new class of RNA-based drugs to diseased cells via parental and oral routes. Key research areas include: nanotechnology, RNA delivery, biomaterials engineering, gene therapy.
Piotr KowalskiAssociate Professor
School of Pharmacy email@example.com